cholecystokinin (27-33), t-butyloxycarbonyl-(20987-59-1)
- Name: cholecystokinin (27-33), t-butyloxycarbonyl-
- Synonyms:Caerulein,1-de(5-oxo-L-proline)-2-de-L-glutamine-3-de-L-asparticacid-4-(N-carboxy-L-tyrosine)-5-L-methionine-, 4-tert-butyl ester, hydrogensulfate (ester) (8CI); Cholecystokinin-7 (swine),N-[(1,1-dimethylethoxy)carbonyl]- (9CI); Cerulein S3
- Molecular Formula:C50H65 N9 O15 S3
- Molecular Weight:1128.32
- CAS Registry Number:20987-59-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.20987-59-1 cholecystokinin (27-33), t-butyloxycarbonyl-
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.20987-59-1 cholecystokinin (27-33), t-butyloxycarbonyl-
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.20987-59-1 cholecystokinin (27-33), t-butyloxycarbonyl-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:cholecystokinin (27-33), t-butyloxycarbonyl-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 7610-45-9/Methyl trioxodibromoantimonate(V) ((MeO)3SbBr2)
- 6269-68-7/N-(4-amino-2-methylquinolin-6-yl)benzamide
- 16816-28-7/methyl N-[(benzyloxy)carbonyl]glycylalaninate
- 93164-85-3/Amines, C20-22-alkyldimethyl
- 15500-74-0/Benzonitrile,4-chloro-N-oxide
- 207502-74-7/Isocalanone
- 39964-49-3/[(2Z)-2-(cyclopentylimino)-3-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-5-yl]acetic acid
- 100209-44-7/Protein hydrolyzates,sunflower
- 57734-47-1/5-(aminosulphonyl)-2,3-dimethoxybenzoyl chloride
- 66223-15-2/3-methyl-8-[(4-methylpiperazin-1-yl)methyl]-2,7-dioxaspiro[4.4]nonane-1,6-dione
- 69173-79-1/4-nitro-N-[(E)-phenylmethylidene]aniline
- 85187-85-5/[4-[(2-chlorophenyl)(1-methyl-2-phenyl-1H-indol-3-yl)methylene]-2,5-cyclohexadien-1-ylidene]diethyl methyl sulphate
- 7478-75-3/4-[1-(4-dimethylaminophenyl)but-1-enyl]-N,N-dimethyl-aniline; 2,4,6-trinitrophenol
- 16975-11-4/N-[(20S)-20-(Dimethylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregnan-3β-yl]-N-methylacetamide
- 96548-01-5/1,3,4-Oxadiazole-2(3H)-thione, 5-(((2-methyl-4-quinazolinyl)oxy)methyl)-3-(1-piperidinylmethyl)-
- 90181-99-0/2-hydroxy-4-oxo-3-(phenylcarbonyl)-1,4-dihydroquinoline-6-carboxylic acid
- 73484-89-6/Thiacyclohexadecan-2-one
- 55364-14-2/Phosphatriptycene
- 87860-39-7/FOSTRIECIN SODIUM SALT
- 20987-59-1/cholecystokinin (27-33), t-butyloxycarbonyl-
- 6950-19-2/6-[(2,4-dichlorobenzyl)sulfanyl]-5H-purin-2-amine
- 850429-59-3/4-BROMO-1,2-DIMETHYL-1H-IMIDAZOLE
- 19341-47-0/N,N-dicyclohexyl-3,9-dioxo-2,4,8,10-tetraoxa-3$l^C17H32N2O6P2,9$l^C17H32N2O6P2-diphosphaspiro[5.5]undecane-3,9-diamine
- 170516-41-3/Glycine,N-[2-(carboxymethoxy)-4-[[(2',7'-dichloro-3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)carbonyl]amino]phenyl]-N-(carboxymethyl)-,potassium salt (1:5)
- 191152-92-8/3-[O-5-(3-azido-3-deoxythymidine)2-succinyloxyethylthio]rifamycin S
- 73612-26-7/1-Ethyl-3,4-dihydro-5-methyl-2H-pyrrolium iodide
- 70185-87-4/2,5-BIS[(1,3-DIOXOBUTYL)AMINO]BENZENESULFONIC ACID
- 38998-17-3/2,3-DIMETHYLANISALDEHYDE
- 85005-27-2/Fatty acids, C14-18-branched and linear, esters with trimethylolpropane
- 6972-14-1/1,2,5-Thiadiazole-3-carboxylicacid,4-amino-,hydrazide(7CI,9CI)